Exome sequencing concentrates next-generation sequencing (NGS) depth on the 1%–1.5% of the human genome that encodes protein, a fraction estimated to harbor approximately 85% of disease-causing ...
To address these limitations, we developed noninvasive prenatal screening using deep trio-exome sequencing; this comprehensive noninvasive method has high sensitivity for detecting fetal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results